DE2549680C2 - - Google Patents

Info

Publication number
DE2549680C2
DE2549680C2 DE2549680A DE2549680A DE2549680C2 DE 2549680 C2 DE2549680 C2 DE 2549680C2 DE 2549680 A DE2549680 A DE 2549680A DE 2549680 A DE2549680 A DE 2549680A DE 2549680 C2 DE2549680 C2 DE 2549680C2
Authority
DE
Germany
Prior art keywords
tetrahydrofuran
ethanol
lyophilized
gangliosides
dialyzed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2549680A
Other languages
German (de)
English (en)
Other versions
DE2549680A1 (de
Inventor
Luigi Abano Terme Padua/Padova It Vecchia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fidia SpA
Original Assignee
Fidia SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia SpA filed Critical Fidia SpA
Publication of DE2549680A1 publication Critical patent/DE2549680A1/de
Application granted granted Critical
Publication of DE2549680C2 publication Critical patent/DE2549680C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19752549680 1975-08-13 1975-11-05 Arzneimittel zur behandlung von ueberleitungsstoerungen des zentralen und peripheren nervensystems Granted DE2549680A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT26323/75A IT1046051B (it) 1975-08-13 1975-08-13 Nuova applicazione terapeutica dei gangliosidi e procedimento per la loro estrazione

Publications (2)

Publication Number Publication Date
DE2549680A1 DE2549680A1 (de) 1977-02-24
DE2549680C2 true DE2549680C2 (fr) 1988-05-11

Family

ID=11219226

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752549680 Granted DE2549680A1 (de) 1975-08-13 1975-11-05 Arzneimittel zur behandlung von ueberleitungsstoerungen des zentralen und peripheren nervensystems

Country Status (7)

Country Link
JP (2) JPS5234912A (fr)
AT (1) AT352296B (fr)
BE (1) BE843695A (fr)
DE (1) DE2549680A1 (fr)
ES (1) ES441233A1 (fr)
FR (1) FR2320760A1 (fr)
IT (1) IT1046051B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2451194A1 (fr) * 1979-03-16 1980-10-10 Merieux Inst Nouveau medicament a base de ganglioside notamment pour le traitement du cholera, et compositions pharmaceutiques le contenant
US4347244A (en) * 1979-03-16 1982-08-31 Societe Anonyme Dite: Institut Merieux Ganglioside containing compositions for treating diarrhea
CA1168980A (fr) * 1980-04-17 1984-06-12 Rolf Schafer Compositions cicatrisantes
EP0058665B1 (fr) * 1980-05-09 1986-02-26 LEFFLER, Hakon Derives d'hydrate de carbone pour inhiber l'adherence bacterienne
ATE42301T1 (de) * 1983-05-27 1989-05-15 Shanksville Corp N V Abschaffung von transplantatabstossreaktion in der organtransplantation.
JPS59222424A (ja) * 1983-06-01 1984-12-14 Katsutaka Nagai 神経障害疾患治療剤
IT1177863B (it) * 1984-07-03 1987-08-26 Fidia Farmaceutici Una miscela gangliosidica come agente terapeutico capare di eliminare il dolore nele neuropatie periferiche
JPH01228997A (ja) * 1988-03-10 1989-09-12 Mect Corp シアロシルグリセライド類及びその製造方法
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
AR241751A1 (es) * 1989-07-12 1992-12-30 Beta Lab Sa Procedimiento para obtener mezclas de gangliosidos para el tratamiento de enfermedades psico-organicas y del caracter.
IT1232176B (it) 1989-07-27 1992-01-25 Fidia Farmaceutici Derivati di-lisogangliosidi
IT1238346B (it) * 1989-11-14 1993-07-13 Gangliosidi modificati e loro derivati funzionali.
JPH0580009A (ja) * 1991-09-20 1993-03-30 Kubota Corp 炭酸濃度測定方法
JPH0580010A (ja) * 1991-09-25 1993-03-30 Kubota Corp 気体中の炭酸ガス濃度測定方法
JP4005115B1 (ja) * 2007-02-08 2007-11-07 日本臓器製薬株式会社 疼痛疾患治療剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT127981B (de) * 1929-06-07 1932-04-25 Schering Kahlbaum Ag Verfahren zur Herstellung eines die zentralen Tätigkeiten fördernden und regulierenden Reizstoffes.
CH193176A (de) * 1936-12-08 1937-09-30 Richter Arthur Verfahren zur Gewinnung eines Wirkstoffes aus Säugetiergehirn.
US3436413A (en) * 1965-12-21 1969-04-01 Canada Packers Ltd Process for the isolation of phosphatidyl serine

Also Published As

Publication number Publication date
BE843695A (fr) 1976-11-03
JPS62187412A (ja) 1987-08-15
ATA606976A (de) 1979-02-15
JPS6250450B2 (fr) 1987-10-24
JPS6256134B2 (fr) 1987-11-24
ES441233A1 (es) 1977-03-16
FR2320760B1 (fr) 1978-11-17
FR2320760A1 (fr) 1977-03-11
IT1046051B (it) 1980-06-30
AT352296B (de) 1979-09-10
DE2549680A1 (de) 1977-02-24
JPS5234912A (en) 1977-03-17

Similar Documents

Publication Publication Date Title
DE2549680C2 (fr)
EP0326034B1 (fr) Preparation combinée pour le traitement des maladies et desordres des cellules et des fibres nerveuses
DE3750785T2 (de) Oligosaccharide von Heparin mit einer Affinität für Faktoren von Zellwachstum.
DE69731610T2 (de) Orale verabreichung wirksamer mengen von hyaluronsäure
DE2911670A1 (de) Arzneimittel zur therapeutischen behandlung von peripheren vaskularen erkrankungen
WO2000074703A2 (fr) Agent therapeutique comportant de la botulinum-neurotoxine de botulinum
DE69833333T2 (de) Pharmazeutische zusammensetzung enthaltend geweihextrakte von cervus nippon mit wachstumsstimulierender aktivität auf hematopoietische stammzellen und megakaryozyten
DE60012230T2 (de) Verwendung einer oligosaccharide enthaltenden dermatologischen zubereitung zur behandlung von hauterkrankungen
DE2903579A1 (de) Verwendung von acetylcarnitin und anderen acylderivaten des carnitins zur behandlung der hyperlipoproteinaemie und hyperlimpidaemie sowie arzneimittel
DE3537656C2 (fr)
EP1611893B1 (fr) Remede contre une lesion nerveuse
DE2735411A1 (de) Verfahren zur herstellung von acellulaeren vaccinen und nach diesem verfahren gewonnene vaccine
CH642085A5 (de) Verfahren zur gewinnung der polaren fraktion mit antipsoriatischer wirksamkeit eines extraktes aus farnpflanzen sowie ein gemaess diesem verfahren hergestelltes praeparat.
DE2547105A1 (de) N-acetyl-muramyl-l-alanyl-d-isoglutamin enthaltende oelfreie adjuvanzien
DE60036639T2 (de) Verwendung von sumsoo-extrakt in pharmazeutischen verbindungen zur prävention und behandlung erektiler impotenz
AT396588B (de) Verfahren zur herstellung von therapeutisch wirksamen ethern polycyclischer verbindungen
DE3787971T2 (de) Aktives prinzip, isoliert aus haigeweben.
DE602004006024T2 (de) Pharmazeutische zusammensetzung mit einem zink/hyaluronat-komplex zur behandlung von multipler sklerose
DE2605576C3 (de) Verfahren zum Isolieren der Proteasen Papain,,Chimopapain, Lysozym und Proteinase X aus dem Milchsaft von Carica papya und Verwendung der isolierten Proteasen zur Herstellung von sterilisierten und Iyophilisirten orthopädischen, neurochirurgischen oder ophthalmologischen Präparaten
DE3883979T2 (de) Zusammensetzung auf der basis von cyclopolygalakturonsäure und verwendung derselben.
DE2723451A1 (de) Polyribonucleotide, verfahren zu ihrer herstellung und ihre verwendung als oder in arzneimitteln
CH654316A5 (de) 4-amino-1beta-d-ribofuranosyl-1h-imidazo(4,5-c)pyridin als mittel fuer die behandlung von entzuendungen.
DE3817762C2 (fr)
DE2546001A1 (de) Immunostimulierende phospholipide und sie enthaltende arzneimittel
DE2745943C2 (fr)

Legal Events

Date Code Title Description
OD Request for examination
8128 New person/name/address of the agent

Representative=s name: SCHWABE, H., DIPL.-ING. SANDMAIR, K., DIPL.-CHEM.

D2 Grant after examination
8364 No opposition during term of opposition